Cargando…

Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine

The purpose of this research was to develop mouth dissolve tablets of cinnarizine by effervescent, superdisintegrant addition and sublimation methods. All the three formulations were evaluated for disintegration time, hardness and friability, among these superdisintegrant addition method showed lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, B. P., Patel, J. K., Rajput, G. C., Thakor, R. S.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013568/
https://www.ncbi.nlm.nih.gov/pubmed/21218071
http://dx.doi.org/10.4103/0250-474X.73930
_version_ 1782195283953713152
author Patel, B. P.
Patel, J. K.
Rajput, G. C.
Thakor, R. S.
author_facet Patel, B. P.
Patel, J. K.
Rajput, G. C.
Thakor, R. S.
author_sort Patel, B. P.
collection PubMed
description The purpose of this research was to develop mouth dissolve tablets of cinnarizine by effervescent, superdisintegrant addition and sublimation methods. All the three formulations were evaluated for disintegration time, hardness and friability, among these superdisintegrant addition method showed lowest disintegration time; hence it was selected for further studies. Further nine batches (B1-B9) were prepared by using crospovidone, croscarmellose sodium and L-HPC in different concentrations such as 5, 7.5 and 10%. All the formulations were evaluated for weight variation, hardness, friability, drug content, in vitro disintegration time, wetting time, in vitro dissolution. Formulation with 10% L-HPC showed the less disintegration time (25.3 s) and less wetting time (29.1 s). In vitro dissolution studies showed total drug release at the end of 6 min.
format Text
id pubmed-3013568
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30135682011-01-07 Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine Patel, B. P. Patel, J. K. Rajput, G. C. Thakor, R. S. Indian J Pharm Sci Short Communications The purpose of this research was to develop mouth dissolve tablets of cinnarizine by effervescent, superdisintegrant addition and sublimation methods. All the three formulations were evaluated for disintegration time, hardness and friability, among these superdisintegrant addition method showed lowest disintegration time; hence it was selected for further studies. Further nine batches (B1-B9) were prepared by using crospovidone, croscarmellose sodium and L-HPC in different concentrations such as 5, 7.5 and 10%. All the formulations were evaluated for weight variation, hardness, friability, drug content, in vitro disintegration time, wetting time, in vitro dissolution. Formulation with 10% L-HPC showed the less disintegration time (25.3 s) and less wetting time (29.1 s). In vitro dissolution studies showed total drug release at the end of 6 min. Medknow Publications 2010 /pmc/articles/PMC3013568/ /pubmed/21218071 http://dx.doi.org/10.4103/0250-474X.73930 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Patel, B. P.
Patel, J. K.
Rajput, G. C.
Thakor, R. S.
Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
title Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
title_full Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
title_fullStr Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
title_full_unstemmed Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
title_short Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
title_sort formulation and evaluation of mouth dissolving tablets of cinnarizine
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013568/
https://www.ncbi.nlm.nih.gov/pubmed/21218071
http://dx.doi.org/10.4103/0250-474X.73930
work_keys_str_mv AT patelbp formulationandevaluationofmouthdissolvingtabletsofcinnarizine
AT pateljk formulationandevaluationofmouthdissolvingtabletsofcinnarizine
AT rajputgc formulationandevaluationofmouthdissolvingtabletsofcinnarizine
AT thakorrs formulationandevaluationofmouthdissolvingtabletsofcinnarizine